Oxidative stress partially contributes to iron-induced alpha-synuclein aggregation in SK-N-SH cells

Neurotoxicity Research

Volumn 19, Issue 3, 2011, Pages 435-442

  Li, Wenjing ^a   Jiang, Hong ^a   Song, Ning ^a   Xie, Junxia ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Alpha synuclein; Iron; Iron regulatory protein; Iron responsive element; Oxidative stress; Parkinson's disease; Vitamin E

Indexed keywords

ALPHA SYNUCLEIN; ALPHA TOCOPHEROL; FERRIC ION; FERROUS ION; IRON REGULATORY FACTOR; MESSENGER RNA; REACTIVE OXYGEN METABOLITE;

5' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CELL LOSS; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IRON RESPONSIVE ELEMENT; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; UPREGULATION;

ALPHA-SYNUCLEIN; CELL LINE, TUMOR; CELL SURVIVAL; FERRIC COMPOUNDS; FERROUS COMPOUNDS; HUMANS; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; RNA, MESSENGER; UP-REGULATION;

EID: 79951950516     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12640-010-9187-x     Document Type: Article

References (39)

1. M Baba S Nakajo PH Tu T Tomita K Nakaya VM Lee JQ Trojanowski T Iwatsubo 1998 Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies Am J Pathol 152 879 884 1:CAS:528:DyaK1cXivVKgsbc%3D 9546347 (Pubitemid 28173348)
2. MC Bennett 2005 The role of alpha-synuclein in neurodegenerative diseases Pharmacol Ther 105 311 331 1:CAS:528:DC%2BD2MXhvVCjt7k%3D 10.1016/j.pharmthera. 2004.10.010 15737408 (Pubitemid 40292724)
3. D Berg H Hochstrasser 2006 Iron metabolism in Parkinsonian syndromes Mov Disord 21 1299 1310 10.1002/mds.21020 16817199 (Pubitemid 44613277)
4. Bharathi SS Indi KS Rao 2007 Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study Neurosci Lett 424 78 82 1:CAS:528:DC%2BD2sXpsFGru7g%3D 10.1016/j.neulet.2007.06.052 17714865 (Pubitemid 47285498)
5. AI Bush 2000 Metals and neuroscience Curr Opin Chem Biol 4 184 191 1:CAS:528:DC%2BD3cXisVaiu7s%3D 10.1016/S1367-5931(99)00073-3 10742195 (Pubitemid 30189310)
6. NB Cole DD Murphy J Lebowitz L Di Noto RL Levine RL Nussbaum 2005 Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments J Biol Chem 280 9678 9690 1:CAS:528:DC%2BD2MXitVChsLc%3D 10.1074/jbc.M409946200 15615715 (Pubitemid 40409666)
7. DT Dexter FR Wells AJ Lees F Agid Y Agid P Jenner CD Marsden 1989 Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease J Neurochem 52 1830 1836 1:CAS:528: DyaL1MXkslGrs7k%3D 10.1111/j.1471-4159.1989.tb07264.x 2723638 (Pubitemid 19140770)
8. JE Duda VM Lee JQ Trojanowski 2000 Neuropathology of synuclein aggregates J Neurosci Res 61 121 127 1:CAS:528:DC%2BD3cXkslOgsbc%3D 10.1002/1097- 4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4 10878583 (Pubitemid 30451798)
9. AL Friedlich RE Tanzi JT Rogers 2007 The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element Mol Psychiatry 12 222 223 1:CAS:528:DC%2BD2sXitFCitbk%3D 10.1038/sj.mp.4001937 17325711 (Pubitemid 46328508)
10. N Golts H Snyder M Frasier C Theisler P Choi B Wolozin 2002 Magnesium inhibits spontaneous and iron-induced aggregation of alpha-synuclein J Biol Chem 277 16116 16123 1:CAS:528:DC%2BD38Xjs1Wjtb4%3D 10.1074/jbc.M107866200 11850416 (Pubitemid 34967897)
11. PF Good CW Olanow DP Perl 1992 Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study Brain Res 593 343 346 1:CAS:528:DyaK3sXltVei 10.1016/0006-8993(92)91334-B 1450944
12. EC Hirsch JP Brandel P Galle F Javoy-Agid Y Agid 1991 Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis J Neurochem 56 446 451 1:CAS:528:DyaK3MXnvFKitA%3D%3D 10.1111/j.1471-4159.1991.tb08170.x 1988548 (Pubitemid 21901982)
13. H Jiang Z Luan J Wang J Xie 2006 Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload Neurochem Int 49 605 609 1:CAS:528:DC%2BD28XhtVOrtrnE 10.1016/j.neuint.2006.04.015 16806586 (Pubitemid 44528090)
14. JP Kehrer 2000 The Haber-Weiss reaction and mechanisms of toxicity Toxicology 149 43 50 1:CAS:528:DC%2BD3cXlvV2htrs%3D 10.1016/S0300-483X(00)00231- 6 10963860 (Pubitemid 30645786)
15. M Kostka T Hogen KM Danzer J Levin M Habeck A Wirth R Wagner CG Glabe S Finger U Heinzelmann P Garidel W Duan CA Ross H Kretzschmar A Giese 2008 Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers J Biol Chem 283 10992 11003 1:CAS:528:DC%2BD1cXksFagurg%3D 10.1074/jbc. M709634200 18258594
16. R Kruger W Kuhn T Muller D Woitalla M Graeber S Kosel H Przuntek JT Epplen L Schols O Riess 1998 Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease Nat Genet 18 106 108 1:CAS:528: DyaK1cXosFCntA%3D%3D 10.1038/ng0298-106 9462735
17. HJ Lee M Chun KV Kandror 2001 Tip60 and HDAC7 interact with the endothelin receptor a and may be involved in downstream signaling J Biol Chem 276 16597 16600 1:CAS:528:DC%2BD3MXjvFGjtbc%3D 10.1074/jbc.C000909200 11262386
18. WR Martin M Wieler M Gee 2008 Midbrain iron content in early Parkinson disease: a potential biomarker of disease status Neurology 70 1411 1417 1:CAS:528:DC%2BD1cXksFantr8%3D 10.1212/01.wnl.0000286384.31050.b5 18172063 (Pubitemid 351521933)
19. AE Oakley JF Collingwood J Dobson G Love HR Perrott JA Edwardson M Elstner CM Morris 2007 Individual dopaminergic neurons show raised iron levels in Parkinson disease Neurology 68 1820 1825 1:STN:280:DC%2BD2szgsVynuw%3D%3D 10.1212/01.wnl.0000262033.01945.9a 17515544 (Pubitemid 46791395)
20. D Olivares X Huang L Branden NH Greig JT Rogers 2009 Physiological and pathological role of alpha-synuclein in parkinson's disease through iron mediated oxidative stress: the role of a putative iron-responsive element Int J Mol Sci 10 1226 1260 1:CAS:528:DC%2BD1MXjvVSjsLo%3D 10.3390/ijms10031226 19399246
21. N Ostrerova-Golts L Petrucelli J Hardy JM Lee M Farer B Wolozin 2000 The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity J Neurosci 20 6048 6054 1:CAS:528:DC%2BD3cXlvVGjs7k%3D 10934254 (Pubitemid 30658398)
22. Y Peng C Wang HH Xu YN Liu F Zhou 2010 Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes J Inorg Biochem 104 365 370 1:CAS:528:DC%2BC3cXitVKitbw%3D 10.1016/j.jinorgbio. 2009.11.005 20005574
23. MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer ES Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos WG Johnson AM Lazzarini RC Duvoisin G Di Iorio LI Golbe RL Nussbaum 1997 Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 2045 2047 1:CAS:528:DyaK2sXkt1altr4%3D 10.1126/science.276.5321.2045 9197268 (Pubitemid 27443610)
24. P Riederer E Sofic WD Rausch B Schmidt GP Reynolds K Jellinger MB Youdim 1989 Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains J Neurochem 52 515 520 1:CAS:528:DyaL1MXhtFals78%3D 10.1111/j.1471-4159. 1989.tb09150.x 2911028 (Pubitemid 19037617)
25. JW Ryu KH Hong JH Maeng JB Kim J Ko JY Park KU Lee MK Hong SW Park YH Kim KH Han 2004 Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration Arterioscler Thromb Vasc Biol 24 864 870 1:CAS:528:DC%2BD2cXjsFSntbk%3D 10.1161/01.ATV.0000125705.28058.eb 15016641 (Pubitemid 38620864)
26. AB Singleton M Farrer J Johnson A Singleton S Hague J Kachergus M Hulihan T Peuralinna A Dutra R Nussbaum S Lincoln A Crawley M Hanson D Maraganore C Adler MR Cookson M Muenter M Baptista D Miller J Blancato J Hardy K Gwinn-Hardy 2003 Alpha-Synuclein locus triplication causes Parkinson's disease Science 302 841 1:CAS:528:DC%2BD3sXoslehsbc%3D 10.1126/science.1090278 14593171 (Pubitemid 37339619)
27. N Song J Wang H Jiang JX Xie 2010 Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease Free Radic Biol Med 48 332 341 1:CAS:528:DC%2BC3cXps1Cg 10.1016/j.freeradbiomed.2009. 11.004 19913091
28. MG Spillantini ML Schmidt VM Lee JQ Trojanowski R Jakes M Goedert 1997 Alpha-synuclein in Lewy bodies Nature 388 839 840 1:CAS:528:DyaK2sXlslWru7o%3D 10.1038/42166 9278044 (Pubitemid 27377048)
29. MG Spillantini RA Crowther R Jakes M Hasegawa M Goedert 1998 Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies Proc Natl Acad Sci USA 95 6469 6473 1:CAS:528:DyaK1cXjtlKgtLo%3D 10.1073/pnas.95.11.6469 9600990 (Pubitemid 28249037)
30. VN Uversky 2007 Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation J Neurochem 103 17 37 1:CAS:528:DC%2BD2sXhtF2qu7nM 17623039 (Pubitemid 47407730)
31. VN Uversky J Li AL Fink 2001 Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure J Biol Chem 276 44284 44296 1:CAS:528:DC%2BD3MXos12nurw%3D 10.1074/jbc.M105343200 11553618
32. J Wang H Jiang JX Xie 2004 Time dependent effects of 6-OHDA lesions on iron level and neuronal loss in rat nigrostriatal system Neurochem Res 29 2239 2243 1:CAS:528:DC%2BD2cXhtVGitrrK 10.1007/s11064-004-7031-5 15672545 (Pubitemid 40036895)
33. J Wang H Jiang JX Xie 2007 Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats Eur J Neurosci 25 2766 2772 10.1111/j.1460-9568.2007.05515.x 17561842 (Pubitemid 46888831)
34. P Wardman LP Candeias 1996 Fenton chemistry: an introduction Radiat Res 145 523 531 1:CAS:528:DyaK28XislCmu7c%3D 10.2307/3579270 8619017 (Pubitemid 26127159)
35. J Yang Y Su A Richmond 2007 Antioxidants tiron and N-acetyl-l-cysteine differentially mediate apoptosis in melanoma cells via a reactive oxygen species-independent NF-kappaB pathway Free Radic Biol Med 42 1369 1380 1:CAS:528:DC%2BD2sXjslGksro%3D 10.1016/j.freeradbiomed.2007.01.036 17395010 (Pubitemid 46467273)
36. JJ Zarranz J Alegre JC Gomez-Esteban E Lezcano R Ros I Ampuero L Vidal J Hoenicka O Rodriguez B Atares V Llorens E Gomez Tortosa T del Ser DG Munoz JG de Yebenes 2004 The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia Ann Neurol 55 164 173 1:CAS:528:DC%2BD2cXhs1Sgtb0%3D 10.1002/ana.10795 14755719 (Pubitemid 38166992)
37. L Zecca D Berg T Arzberger P Ruprecht WD Rausch M Musicco D Tampellini P Riederer M Gerlach G Becker 2005 In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage Mov Disord 20 1278 1285 10.1002/mds.20550 15986424 (Pubitemid 41645902)
38. S Zhang J Wang N Song J Xie H Jiang 2009 Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells Neurobiol Aging 30 1466 1476 1:CAS:528: DC%2BD1MXos12luro%3D 10.1016/j.neurobiolaging.2007.11.025 18191877
39. M Zhou SL Xu B Chen 2009 Dual effects of different concentrations of alpha-synuclein on the neurotoxicity of 6-hydroxydopamine in SH-SY5Y cells Sheng Li Xue Bao 61 324 330 1:CAS:528:DC%2BC3cXmsFKnsQ%3D%3D